{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-002900","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.477804+00:00","generated_at":"2026-05-17T13:12:23.107797+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeward Q2 revenue $5.7M (-15% YoY); net loss $6.6M; resets 2025 guidance","bullets":["Revenue $5.7M, down 15% YoY; traditional product revenue $2.5M (-19% YoY) excluding one-time Medicare benefit.","Net loss $6.6M ($0.58 per share) vs $4.3M ($0.50) in Q2 2024; includes $2.8M goodwill impairment.","Adjusted net loss $3.5M ($0.31 per share); cash burn improved to $3.9M from $5.6M prior year.","Record number of ReWalk units placed for Medicare since fee schedule; new CEO Mark Grant and CFO Almog Adar appointed.","FY 2025 guidance reset to revenue $24-26M and non-GAAP net loss $12-14M."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-002900","json":"https://secwatch.observer/filing/0001178913-25-002900.json","markdown":"https://secwatch.observer/filing/0001178913-25-002900.md","text":"https://secwatch.observer/filing/0001178913-25-002900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325002900/0001178913-25-002900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325002900/zk2533654.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:12:23.107797+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}